Cargando…
A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals
As an essential enzyme of SARS-CoV-2, the COVID-19 pathogen, main protease (M(Pro)) is a viable target to develop antivirals for the treatment of COVID-19. By varying chemical compositions at both P2 and P3 positions and the N-terminal protection group, we synthesized 18 tripeptidyl M(Pro) inhibitor...
Autores principales: | Ma, Yuying, Yang, Kai S., Geng, Zhi Zachary, Alugubelli, Yugendar R., Shaabani, Namir, Vatansever, Erol C., Ma, Xinyu R., Cho, Chia-Chuan, Khatua, Kaustav, Xiao, Jing, Blankenship, Lauren R., Yu, Ge, Sankaran, Banumathi, Li, Pingwei, Allen, Robert, Ji, Henry, Xu, Shiqing, Liu, Wenshe Ray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235293/ https://www.ncbi.nlm.nih.gov/pubmed/35779291 http://dx.doi.org/10.1016/j.ejmech.2022.114570 |
Ejemplares similares
-
A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals
por: Alugubelli, Yugendar R., et al.
Publicado: (2022) -
Evaluation of SARS-CoV-2 Main Protease Inhibitors
Using a Novel Cell-Based Assay
por: Cao, Wenyue, et al.
Publicado: (2022) -
Accurate Mass Identification of an Interfering Water Adduct and Strategies in Development and Validation of an LC-MS/MS Method for Quantification of MPI8, a Potent SARS-CoV-2 Main Protease Inhibitor, in Rat Plasma in Pharmacokinetic Studies
por: Wang, Yang, et al.
Publicado: (2022) -
Hybrid Molecular Structure of the Giant Protease Tripeptidyl Peptidase II
por: Chuang, Crystal K., et al.
Publicado: (2010) -
The Enigma of Tripeptidyl-Peptidase II: Dual Roles in Housekeeping
and Stress
por: Preta, Giulio, et al.
Publicado: (2010)